We are live on ! Find out more
VIOT

Viomi Technology

12 hedge funds and large institutions have $996K invested in Viomi Technology in 2024 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

17% more capital invested

Capital invested by funds: $855K → $996K (+$141K)

0% more funds holding

Funds holding: 1212 (0)

0% more first-time investments, than exits

New positions opened: 4 | Existing positions closed: 4

0.06% less ownership

Funds ownership: 0.83%0.77% (-0.06%)

50% less repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 2

Holders
12
Holders Change
Holders Change %
0%
% of All Funds
0.17%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
4
Increased
1
Reduced
2
Closed
4
Calls
Puts
Net Calls
Net Calls Change

VIOT Hedge Fund Activity: Q1 2024 in Review

12 of the 6,943 institutional investors tracked by Wall St. Rank reported a position in Viomi Technology (VIOT) for Q1 2024, worth a combined $996K — up 17% from $855K a quarter earlier.

Fund positioning in VIOT was balanced in Q1 2024: 4 funds opened new positions, 4 closed out, 1 added to existing stakes and 2 trimmed.

The largest buyer was Federation des caisses Desjardins du Quebec, opening a new position worth an estimated $27.4K. The largest seller was Acadian Asset Management, cutting an estimated $73.2K.

  • 12 institutional investors held Viomi Technology (VIOT) as of Q1 2024, unchanged from Q4 2023.
  • Funds reported $996K of Viomi Technology stock for Q1 2024, up 17% quarter-over-quarter.
  • 4 funds opened new Viomi Technology positions in Q1 2024 and 4 closed out, a net change of 0 holders.
  • The largest Viomi Technology buyer in Q1 2024 was Federation des caisses Desjardins du Quebec, an estimated $27.4K added.
  • The largest Viomi Technology seller in Q1 2024 was Acadian Asset Management, an estimated $73.2K sold.

Based on aggregated 13F filings for Q1 2024.